UnitedHealth Group Inc. (NYSE:UNH) issued its quarterly earnings data on Tuesday. The healthcare conglomerate reported $2.17 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.08 by $0.09. The firm had revenue of $46.30 billion for the quarter, compared to analyst estimates of $46.09 billion. UnitedHealth Group had a return on equity of 19.08% and a net margin of 3.51%. During the same period last year, the company earned $1.77 EPS.

UnitedHealth Group (NYSE:UNH) opened at 134.13 on Tuesday. The stock has a 50 day moving average price of $136.95 and a 200 day moving average price of $136.65. The stock has a market capitalization of $127.74 billion, a P/E ratio of 20.99 and a beta of 0.57. UnitedHealth Group has a 12 month low of $107.51 and a 12 month high of $144.48.

Earnings History for UnitedHealth Group (NYSE:UNH)

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 20th. Stockholders of record on Friday, September 9th were given a $0.625 dividend. The ex-dividend date of this dividend was Tuesday, September 6th. This represents a $2.50 annualized dividend and a dividend yield of 1.86%. UnitedHealth Group’s payout ratio is 39.12%.

In other news, Director Richard T. Burke sold 40,000 shares of the stock in a transaction on Wednesday, September 7th. The stock was sold at an average price of $135.31, for a total transaction of $5,412,400.00. Following the completion of the sale, the director now owns 2,003,550 shares in the company, valued at approximately $271,100,350.50. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 1.65% of the company’s stock.

Hedge funds have recently modified their holdings of the stock. Van Hulzen Asset Management LLC acquired a new stake in shares of UnitedHealth Group during the second quarter valued at approximately $104,000. Eubel Brady & Suttman Asset Management Inc. acquired a new stake in shares of UnitedHealth Group during the second quarter valued at approximately $209,000. Bellwether Investment Group LLC acquired a new stake in shares of UnitedHealth Group during the second quarter valued at approximately $220,000. Ancora Advisors LLC acquired a new stake in shares of UnitedHealth Group during the second quarter valued at approximately $238,000. Finally, MCF Advisors LLC raised its stake in shares of UnitedHealth Group by 79.6% in the second quarter. MCF Advisors LLC now owns 1,721 shares of the healthcare conglomerate’s stock valued at $243,000 after buying an additional 763 shares in the last quarter. Hedge funds and other institutional investors own 85.80% of the company’s stock.

A number of brokerages have recently weighed in on UNH. Leerink Swann reiterated an “outperform” rating and issued a $165.00 price objective (up from $155.00) on shares of UnitedHealth Group in a research report on Wednesday, July 20th. FBR & Co reiterated an “outperform” rating and issued a $155.00 price objective (up from $145.00) on shares of UnitedHealth Group in a research report on Wednesday, July 20th. Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $160.00 price objective on the stock in a research report on Friday, July 22nd. Oppenheimer Holdings Inc. reiterated an “outperform” rating and issued a $161.00 price objective (up from $145.00) on shares of UnitedHealth Group in a research report on Friday, July 22nd. Finally, Credit Suisse Group AG reiterated a “buy” rating and issued a $155.00 price objective (up from $148.00) on shares of UnitedHealth Group in a research report on Wednesday, July 20th. One analyst has rated the stock with a hold rating, twenty-five have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus price target of $155.35.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

5 Day Chart for NYSE:UNH

Receive News & Stock Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related stocks with our FREE daily email newsletter.